Last reviewed · How we verify
NCT03803306
Vedic Medical Astrology in Essential Hypertension
NA trial testing Vedic Medical Astrology in Essential Hypertension in 68 participants. Completed in 6 January 2019.
15 December 2018
Quick facts
| Lead sponsor | NMP Medical Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 68 |
| Start date | 12 July 2018 |
| Primary completion | 15 December 2018 |
| Estimated completion | 6 January 2019 |
| Sites | 1 location across India |
Drugs / interventions tested
- Vedic Medical Astrology
- Placebo vedic medical astrology (PMA)
Conditions studied
- Essential Hypertension — all drugs for Essential Hypertension →
Sponsor
NMP Medical Research Institute
Who can join
Adults 35 to 60, any sex, with Essential Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Previous studies have explored the correlation and impact of astrological events in relation of diseases, health concerns and relationship between birth chart and disease risk. Cardiovascular conditions, sleep and fertility were found significantly associated with moon phase. However, to best of our knowledge no study has documented the impact of astrological intervention in disease management. This is a randomised, multi-center, double blind placebo controlled clinical trial with two parallel arms. This trial aims to evaluate the effectiveness of Vedic medical astrological intervention for patients with mild to moderate hypertension,with respect to decreasing their blood pressure and improving their quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03803306
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Essential Hypertension
Currently open trials in the same condition.
- NCT07282145 — Safety and Pharmacokinetics Study of BCD101 in Healthy Volunteers · Phase 1 · recruiting
- NCT06778239 — Childhood-Onset Essential Hypertension Natural History Study · recruiting
- NCT07051811 — To Evaluate the Safety and Efficacy of a Single-Use IVUS Ablation for Primary Hypertension · NA · recruiting
- NCT06643819 — Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A · Phase 3 · recruiting
- NCT05880056 — Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian P · Phase 4 · recruiting
Other NMP Medical Research Institute trials
Trials by the same sponsor.
- NCT04974853 — Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation · NA · completed
- NCT04920773 — Community-based Post-exposure Prophylaxis for COVID-19 · NA · completed
- NCT04113512 — Yoga Nasal Irrigation in the Treatment of Chronic Tension Type Headache · NA · completed
- NCT04113460 — The Effectiveness Yoga@Work Among Office Workers With Chronic Nonspecific Neck Pain (CNNP) · NA · completed
- NCT04113473 — An Evaluation of Yoga Therapy for Cervical Spondylosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03803306 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NMP Medical Research Institute
- Last refreshed: 14 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03803306.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing